Dalal Anupam — SEC Form 4 filings
SEC reporting owner CIK 1602474. 4 Form 4 filings on record with FilingPulse; latest filed 2026-07-30.
Transaction summary — filings shown
Covers all 4 filings on record, filed 2024-06-14 to 2026-07-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 5.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | Director | 4 | — | — | 5 |
Form 4 filings — Dalal Anupam
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-30 | 4 | Whitehawk Therapeutics, Inc. (WHWK) | Grant/award (A): 1,275,510 @ $3.92 · Grant/award (A): 38,040 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Whitehawk Therapeutics, Inc. (WHWK) | Grant/award (A): 40,006 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | Aadi Bioscience, Inc. (AADI) | Grant/award (A): 1,561,000 @ $2.40 | EDGAR |
| 2024-06-14 | 4 | Aadi Bioscience, Inc. (AADI) | Grant/award (A): 45,832 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1602474 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →